Has this medication been approved by the US FDA for COVID-19?
Favipiravir
Status:
Open Jun 11, 2026 - 08:57 AM
1answer
Answer
Jun 11, 2026 - 08:57 AM
The US Food and Drug Administration (FDA) authorized it for emergency use as a potential COVID-19 treatment in May 2020. FDA authorization, even for emergency use, indicates a level of confidence in the medication’s safety and potential effectiveness during public health emergencies.
View More Product Details
Favipiravir
Faviparivir is a pyrazinecarboxamide-derivativ
e antiviral medication originally from Japan and used to treat influenza.
View Details
View all Favipiravir Questions & Answers
